| Literature DB >> 34282944 |
Yoshikazu Furuta1, Cheng Cheng2, Tuvshinzaya Zorigt1, Atmika Paudel1, Shun Izumi1,3, Mai Tsujinouchi1, Tomoko Shimizu1, Wim G Meijer2, Hideaki Higashi1.
Abstract
AtxA, the master virulence regulator of Bacillus anthracis, regulates the expression of three toxins and genes for capsule formation that are required for the pathogenicity of B. anthracis. Recent transcriptome analyses showed that AtxA affects a large number of genes on the chromosome and plasmids, suggesting a role as a global regulator. However, information on genes directly regulated by AtxA is scarce. In this work, we conducted genome-wide analyses and cataloged the binding sites of AtxA in vivo and transcription start sites on the B. anthracis genome. By integrating these results, we detected eight genes as direct regulons of AtxA. These consisted of five protein-coding genes, including two of the three toxin genes, and three genes encoding the small RNAs XrrA and XrrB and a newly discovered 95-nucleotide small RNA, XrrC. Transcriptomes from single-knockout mutants of these small RNAs revealed changes in the transcription levels of genes related to the aerobic electron transport chain, heme biosynthesis, and amino acid metabolism, suggesting their function for the control of cell physiology. These results reveal the first layer of the gene regulatory network for the pathogenicity of B. anthracis and provide a data set for the further study of the genomics and genetics of B. anthracis. IMPORTANCE Bacillus anthracis is the Gram-positive bacterial species that causes anthrax. Anthrax is still prevalent in countries mainly in Asia and Africa, where it causes economic damage and remains a public health issue. The mechanism of pathogenicity is mainly explained by the three toxin proteins expressed from the pXO1 plasmid and by proteins involved in capsule formation expressed from the pXO2 plasmid. AtxA is a protein expressed from the pXO1 plasmid that is known to upregulate genes involved in toxin production and capsule formation and is thus considered the master virulence regulator of B. anthracis. Therefore, understanding the detailed mechanism of gene regulation is important for the control of anthrax. The significance of this work lies in the identification of genes that are directly regulated by AtxA via genome-wide analyses. The results reveal the first layer of the gene regulatory network for the pathogenicity of B. anthracis and provide useful resources for a further understanding of B. anthracis.Entities:
Keywords: Bacillus anthracis; Cappable-seq; ChIP-seq; DNA-binding proteins; small RNA; transcription factors; transcriptional regulation; virulence factors
Year: 2021 PMID: 34282944 PMCID: PMC8407390 DOI: 10.1128/mSystems.00291-21
Source DB: PubMed Journal: mSystems ISSN: 2379-5077 Impact factor: 6.496
AtxA-binding regions
| Binding site | Replicon | ChIP-seq | Cappable-seq | Gene | Old locus tag | ||||
|---|---|---|---|---|---|---|---|---|---|
| Start position | End position | Width (bp) | Whole FDR | TSS | TSS log2 FC | ||||
| AtxA_BS_01 | pXO1 | 105401 | 106100 | 700 | 5.1E−06 | 105924 (−) | 4.16 |
| NA |
| AtxA_BS_02 | pXO1 | 106351 | 106850 | 500 | 6.6E−03 | 106705 (+) | 4.80 | GBAA_RS28950 (S-layer protein) | GBAA_pXO1_0124 |
| AtxA_BS_03 | pXO1 | 110651 | 111300 | 650 | 2.3E−05 | NA | NA | NA | NA |
| AtxA_BS_04 | pXO1 | 119401 | 119800 | 400 | 3.9E−09 | 119551 (−) | 4.38 | GBAA_RS29020 (hypothetical protein) | GBAA_pXO1_0137 |
| AtxA_BS_05 | pXO1 | 129301 | 129600 | 300 | 3.6E−03 | 129517 (+) | 4.77 | GBAA_RS29065 (hypothetical protein) | GBAA_pXO1_0148 |
| AtxA_BS_06 | pXO1 | 131251 | 131450 | 200 | 5.0E−05 | 131385 (+) | 4.55 |
| NA |
| AtxA_BS_07 | pXO1 | 141601 | 141950 | 350 | 5.1E−06 | 141844 (+) | 5.05 |
| NA |
| AtxA_BS_08 | pXO1 | 143201 | 144000 | 800 | 1.2E−05 | 143721 (+) | 4.18 | GBAA_RS29110 ( | GBAA_pXO1_0164 |
| AtxA_BS_09 | pXO1 | 147501 | 147850 | 350 | 5.1E−06 | NA | NA | NA | NA |
| AtxA_BS_10 | pXO1 | 151601 | 152450 | 850 | 5.1E−05 | 151815 (−) | 3.76 | GBAA_RS29135 ( | GBAA_pXO1_0172 |
| AtxA_BS_11 | Chromosome | 4964501 | 4964800 | 300 | 4.6E−08 | NA | NA | NA | NA |
Whole FDR, false discovery rate for the whole AtxA-binding region; TSS, transcription start site; FC, fold change; NA, not applicable; (+), forward strand; (−), reverse strand.
FIG 1ChIP-qPCR. (A) ChIP samples isolated from cells grown under high CO2/bicarbonate levels (15% CO2 and 0.8% NaHCO3). (B) ChIP samples isolated from cells grown under low CO2/bicarbonate levels (no additional CO2 or bicarbonate). PL3 is the marker region of the B. anthracis chromosome that is not expected to bind with AtxA.
FIG 2Sequence motifs and TSSs detected by Cappable-seq. (A) Results of WebLogo analysis of the region spanning positions −49 to +6 of all TSSs detected in the WT strain. (B) TSSs of the three toxin genes. The start codon of each gene is squared. “Ref” indicates TSSs detected in previous literature. See Table S1 in the supplemental material for the reference information. (C) Classification of TSSs in this work.
Classification of TSSs
| Type of TSS | No. of TSS in strain | |||||
|---|---|---|---|---|---|---|
| WT | Δ | |||||
| Chromosome | pXO1 | Total | Chromosome | pXO1 | Total | |
| Intergenic sense | 2,982 | 150 | 3,132 | 3,018 | 131 | 3,149 |
| Intergenic antisense | 458 | 75 | 533 | 421 | 73 | 494 |
| Intragenic sense | 1,499 | 112 | 1,611 | 1,420 | 97 | 1,517 |
| Intragenic antisense | 744 | 68 | 812 | 645 | 52 | 697 |
| Total | 5,683 | 405 | 6,088 | 5,504 | 353 | 5,857 |
See Fig. 2C.
FIG 3AtxA binding and TSS changes in AtxA direct regulons and toxin genes. (A) pagA; (B) lef; (C) cya; (D) GBAA_RS28950; (E) GBAA_RS29020; (F) GBAA_RS29065. The top panels show the ChIP-seq results; red indicates detected AtxA binding. The middle panels show the genomic context around the gene of interest. The bottom panels show the coverage of each position in Cappable-seq on the forward strand of the WT, the reverse strand of the WT, the forward strand of the ΔatxA strain, and the reverse strand of the ΔatxA strain, from the top. TSSs of direct regulons are shown in red. Protein-coding genes are represented by blue arrows.
FIG 4Small RNAs directly regulated by AtxA. (A to C) Integrated view of ChIP-seq and Cappable-seq for XrrA (A), XrrB (B), and XrrC (C). Details are the same as those described in the Fig. 3 legend. Small RNA genes are represented by green arrows. (D) Predicted folding of XrrC. (E) Predicted folding of XrrD. (F) Sequence alignment of XrrC in B. anthracis Sterne and Ames. Nucleotides detected with sequence diversity are marked by “#.”
Annotation of small RNA on pXO1
| Small RNA | Start position | End position | Strand | Size (bases) |
|---|---|---|---|---|
| XrrA | 131385 | 131565 | + | 181 |
| XrrB | 105924 | 105705 | − | 220 |
| XrrC | 141844 | 141938 | + | 95 |
| XrrD | 105408 | 105494 | + | 87 |
B. anthracis strains
| Strain | Description | Reference |
|---|---|---|
| 34F2 |
| |
| BYF10078 | 34F2 with 1× FLAG tag at the C terminus of | This work |
| BYF10054 | 34F2 Δ | This work |
| BYF10081 | 34F2 Δ | This work |
| BYF10080 | 34F2 Δ | This work |
| BYF10107 | 34F2 Δ | This work |
| BYF10082 | 34F2 Δ | This work |
| BYF10109 | 34F2 Δ | This work |
| BYF10108 | 34F2 Δ | This work |
| BYF10110 | 34F2 Δ | This work |
| BYF10008 | 34F2 Δ | This work |
| BYF10009 | 34F2 Δ | This work |
| BYF10121 | 34F2 ΔGBAA_RS28950 | This work |
| BYF10122 | 34F2 ΔGBAA_RS29020 | This work |
| BYF10123 | 34F2 ΔGBAA_RS29065 | This work |
FIG 5Northern blotting of small RNAs. Probes specific for each small RNA and 5S rRNA were hybridized to whole RNA extracted from each strain grown under the high-CO2/bicarbonate conditions (15% CO2 and 0.8% NaHCO3).
FIG 6Volcano plots of transcriptome results. (A) Comparison between the WT and ΔxrrA strains. (B) Comparison between the WT and ΔxrrB strains. (C) Comparison between the WT and ΔxrrC strains.
Gene ontology term enrichment of genes upregulated by XrrA/XrrB
| sRNA and GO term | Fold enrichment | FDR |
|---|---|---|
| XrrA | ||
| Biological process | ||
| Aerobic electron transport chain | 69.87 | 4.04E−03 |
| Cellular respiration | 19.96 | 9.38E−03 |
| Energy derivation by oxidation of organic compounds | 18.23 | 1.12E−02 |
| Generation of precursor metabolites and energy | 11.52 | 1.11E−02 |
| Respiratory electron transport chain | 41.92 | 2.62E−03 |
| Electron transport chain | 19.96 | 1.02E−02 |
| Heme biosynthetic process | 46.58 | 5.45E−03 |
| Pigment biosynthetic process | 34.93 | 2.14E−03 |
| Pigment metabolic process | 33.54 | 1.92E−03 |
| Heme metabolic process | 44.13 | 3.29E−03 |
| Porphyrin-containing compound metabolic process | 39.92 | 1.87E−03 |
| Tetrapyrrole metabolic process | 34.93 | 1.87E−03 |
| Porphyrin-containing compound biosynthetic process | 41.92 | 1.97E−03 |
| Tetrapyrrole biosynthetic process | 38.11 | 1.83E−03 |
| Molecular function | ||
| Oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as an acceptor | 78.6 | 2.50E−02 |
| Oxidoreductase activity, acting on diphenols and related substances as donors | 78.6 | 1.25E−02 |
| XrrB | ||
| Biological process | ||
| Valine biosynthetic process | >100 | 3.91E−02 |
| Valine metabolic process | >100 | 2.87E−02 |
| Isoleucine biosynthetic process | >100 | 3.47E−02 |
| Branched-chain amino acid biosynthetic process | >100 | 3.29E−02 |
| Branched-chain amino acid metabolic process | >100 | 3.65E−02 |
| Isoleucine metabolic process | >100 | 2.60E−02 |